Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
aminophyllin 105 mg/5 ml oral væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing diprophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Diprophylline-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
dyphyllin 300 mg + guaifenesin 300 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
guaifenesin 100 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Siltussin sa 100mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Guaifenesin 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
guaifenesin 1200 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Guaifenesin 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
guaifenesin kapsel med modificeret udløsning a 300 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
guaifenesin kapsel med modificeret udløsning a 600 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
theophyllin med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Theophylline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Ephedrine sulfate 25 mg and guaifenesin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing cetylpyridinium and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
guaifenesin + oxtriphyllin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing ephedrine and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing diprophylline and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing potassium iodide and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
ephedrinsulfat + hydroxyzinhydrochlorid + theophyllin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing masoprocol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
oxtriphyllin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing guaifenesin and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
aminophyllinhydrat tablet med modificeret udløsning a 350 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
aminophyllinhydrat tablet med modificeret udløsning a 225 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
aminophyllinhydrat tabletter med modificeret udløsning a 100 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
allergi over for lægemidler med primær effekt på det muskuloskeletale system |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
1 |